High Density Lipoprotein Deficiency

1

Review clinical trials related to High Density Lipoprotein Deficiency. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Atlantic Lipid Lowering Treatment Optimization Program

Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group (AMG) formed a lipid workgroup chaired by Robert D. Fishberg, MD, and Jeffrey N. Feldman, MD. The overarching goal of the lipid workgroup is to enhance the treatment of lipid disorders in those patients with abnormal lipid levels by improving access to resources at the primary care practice level and specialty level. We aim to develop a model for primary and secondary prevention that integrates guidelines for treatment at the practice level. Our primary objective is to identify high-risk patients by utilizing the electronic health record and partnering with patients' primary care providers to provide comprehensive medical management.

Participants needed: 250
Trial details
Age: 18-120Biological sex: AllType: InterventionalSponsor: Atlantic Health SystemUpdated: Aug 3, 2025Locations: 2
Eligibility criteria

LDL-C ≥160 mg/dL [+7]

Individuals who are pregnant [+3]